A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial
Abstract Objective Postoperative delirium (POD) is a common complication along with poor prognosis in geriatric intertrochanteric fracture (ITF) patients. However, the prevention and treatment of POD remain unclear. Previous studies have confirmed that POD is essentially a consequence of neuro-infla...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-023-03930-2 |
_version_ | 1797795615000756224 |
---|---|
author | Jian-wen Huang Yun-fa Yang Xiao-sheng Gao Zhong-he Xu |
author_facet | Jian-wen Huang Yun-fa Yang Xiao-sheng Gao Zhong-he Xu |
author_sort | Jian-wen Huang |
collection | DOAJ |
description | Abstract Objective Postoperative delirium (POD) is a common complication along with poor prognosis in geriatric intertrochanteric fracture (ITF) patients. However, the prevention and treatment of POD remain unclear. Previous studies have confirmed that POD is essentially a consequence of neuro-inflammatory responses. Dexamethasone is a glucocorticoid with comprehensive anti-inflammatory effects, while a high dose of dexamethasone correlates with many side effects or even adverse consequences. Thus, this prospective study aims to discuss whether a single preoperative low-dose dexamethasone can reduce the impact of POD on geriatric ITF patients with internal fixation surgery. Methods Between June 2020 and October 2022, there were 219 consecutive ITF patients assessed in our department. Of the 219 ITF patients, 160 cases who met the inclusion and exclusion criteria were finally enrolled and randomly allocated to the dexamethasone group and the placebo group (80 geriatric ITF patients in each group) in this prospective study. The patients in the dexamethasone group received intravenous 10 mg (2 ml) dexamethasone while the patients in the placebo group received intravenous 2 ml saline in 30 min before being sent to the operating room, respectively. The baseline characteristics, surgical information, incidence and severity of POD as the efficacy-related outcomes, and infection events and hyperglycemia as safety-related outcomes (adverse events), were collected and analyzed between the two groups. The severity of POD was evaluated by Memorial Delirium Assessment Scale (MDAS) score. Results There were no differences in baseline characteristics and surgical information between the dexamethasone group and the placebo group. The dexamethasone group had a lower incidence of POD than the placebo group within the first 5 days after surgery [(9/80, 11.3% vs. 21/80, 26.3%, RR = 0.83, 95% CI 0.71–0.97, P = 0.015]. The dexamethasone group had lower MDAS scores (Mean ± SD) than the placebo group [13.2 ± 1.0 (range 11 to 15) vs. 15.48 ± 2.9 (range 9 to 20), P = 0.011, effect size = 0.514]. There were no differences in infection events and hyperglycemia between the two groups. Conclusions A single preoperative low-dose dexamethasone may reduce the incidence and severity of POD in geriatric ITF patients with internal fixation surgery. Trial registration: ChiCTR2200055281. |
first_indexed | 2024-03-13T03:20:39Z |
format | Article |
id | doaj.art-e2c9aff21c8e41ed879122e6fb0b7260 |
institution | Directory Open Access Journal |
issn | 1749-799X |
language | English |
last_indexed | 2024-03-13T03:20:39Z |
publishDate | 2023-06-01 |
publisher | BMC |
record_format | Article |
series | Journal of Orthopaedic Surgery and Research |
spelling | doaj.art-e2c9aff21c8e41ed879122e6fb0b72602023-06-25T11:23:05ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2023-06-0118111110.1186/s13018-023-03930-2A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trialJian-wen Huang0Yun-fa Yang1Xiao-sheng Gao2Zhong-he Xu3Department of Orthopaedic Surgery, Guangzhou First People’s Hospital, The Second Affiliated Hospital, School of Medicine, South China University of TechnologyDepartment of Orthopaedic Surgery, Guangzhou First People’s Hospital, The Second Affiliated Hospital, School of Medicine, South China University of TechnologyDepartment of Orthopaedic Surgery, Guangzhou First People’s Hospital, The Second Affiliated Hospital, School of Medicine, South China University of TechnologyDepartment of Orthopaedic Surgery, Guangzhou First People’s Hospital, The Second Affiliated Hospital, School of Medicine, South China University of TechnologyAbstract Objective Postoperative delirium (POD) is a common complication along with poor prognosis in geriatric intertrochanteric fracture (ITF) patients. However, the prevention and treatment of POD remain unclear. Previous studies have confirmed that POD is essentially a consequence of neuro-inflammatory responses. Dexamethasone is a glucocorticoid with comprehensive anti-inflammatory effects, while a high dose of dexamethasone correlates with many side effects or even adverse consequences. Thus, this prospective study aims to discuss whether a single preoperative low-dose dexamethasone can reduce the impact of POD on geriatric ITF patients with internal fixation surgery. Methods Between June 2020 and October 2022, there were 219 consecutive ITF patients assessed in our department. Of the 219 ITF patients, 160 cases who met the inclusion and exclusion criteria were finally enrolled and randomly allocated to the dexamethasone group and the placebo group (80 geriatric ITF patients in each group) in this prospective study. The patients in the dexamethasone group received intravenous 10 mg (2 ml) dexamethasone while the patients in the placebo group received intravenous 2 ml saline in 30 min before being sent to the operating room, respectively. The baseline characteristics, surgical information, incidence and severity of POD as the efficacy-related outcomes, and infection events and hyperglycemia as safety-related outcomes (adverse events), were collected and analyzed between the two groups. The severity of POD was evaluated by Memorial Delirium Assessment Scale (MDAS) score. Results There were no differences in baseline characteristics and surgical information between the dexamethasone group and the placebo group. The dexamethasone group had a lower incidence of POD than the placebo group within the first 5 days after surgery [(9/80, 11.3% vs. 21/80, 26.3%, RR = 0.83, 95% CI 0.71–0.97, P = 0.015]. The dexamethasone group had lower MDAS scores (Mean ± SD) than the placebo group [13.2 ± 1.0 (range 11 to 15) vs. 15.48 ± 2.9 (range 9 to 20), P = 0.011, effect size = 0.514]. There were no differences in infection events and hyperglycemia between the two groups. Conclusions A single preoperative low-dose dexamethasone may reduce the incidence and severity of POD in geriatric ITF patients with internal fixation surgery. Trial registration: ChiCTR2200055281.https://doi.org/10.1186/s13018-023-03930-2Postoperative deliriumDexamethasoneIntertrochanteric fracturesThe elderly |
spellingShingle | Jian-wen Huang Yun-fa Yang Xiao-sheng Gao Zhong-he Xu A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial Journal of Orthopaedic Surgery and Research Postoperative delirium Dexamethasone Intertrochanteric fractures The elderly |
title | A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial |
title_full | A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial |
title_fullStr | A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial |
title_full_unstemmed | A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial |
title_short | A single preoperative low-dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery: an exploratory analysis of a randomized, placebo-controlled trial |
title_sort | single preoperative low dose dexamethasone may reduce the incidence and severity of postoperative delirium in the geriatric intertrochanteric fracture patients with internal fixation surgery an exploratory analysis of a randomized placebo controlled trial |
topic | Postoperative delirium Dexamethasone Intertrochanteric fractures The elderly |
url | https://doi.org/10.1186/s13018-023-03930-2 |
work_keys_str_mv | AT jianwenhuang asinglepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT yunfayang asinglepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT xiaoshenggao asinglepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT zhonghexu asinglepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT jianwenhuang singlepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT yunfayang singlepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT xiaoshenggao singlepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial AT zhonghexu singlepreoperativelowdosedexamethasonemayreducetheincidenceandseverityofpostoperativedeliriuminthegeriatricintertrochantericfracturepatientswithinternalfixationsurgeryanexploratoryanalysisofarandomizedplacebocontrolledtrial |